NEVVI Medicare utilization intelligence

← back

GOLD, JULIEM.D. NPI 1992739742 Clinician

Hematology-Oncology · MOUNT KISCO, NY

Specialty Hematology-Oncology — from billed Medicare claims
Trained JS WEILL MEDICAL COLLEGE, CORNELL UNIVERSITY — medical school, self-reported to CMS
In practice about 24 years since medical school (class of 2002, self-reported to CMS)
Location MOUNT KISCO, NY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 50 codes billed · 13,181 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
OPTUM MEDICAL CARE PC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2016-11

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0897 Injection, denosumab, 1 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
80053 Blood test, comprehensive group of blood chemicals
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
96375 Injection of additional new drug or substance into vein
82728 Ferritin (blood protein) level
J9045 Injection, carboplatin, 50 mg
83615 Lactate dehydrogenase (enzyme) level
83540 Iron level
83550 Iron binding capacity
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96413 Administration of chemotherapy into vein, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
82607 Cyanocobalamin (vitamin b-12) level
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
83735 Magnesium level
82746 Folic acid level, serum
85045 Red blood count, automated test
82378 Carcinoembryonic antigen (cea) protein level
96417 Administration of additional new drug or substance into vein, 1 hour or less
84443 Blood test, thyroid stimulating hormone (tsh)
J1200 Injection, diphenhydramine hcl, up to 50 mg
85652 Red blood cell sedimentation rate, to detect inflammation, automated
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
83010 Haptoglobin (serum protein) level
J3490 Unclassified drugs
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
84439 Thyroxine (thyroid chemical), free
87340 Detection test by immunoassay technique for hepatitis b surface antigen
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
86140 Measurement c-reactive protein for detection of infection or inflammation
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
86803 Hepatitis c antibody measurement
G0008 Administration of influenza virus vaccine
86704 Hepatitis b core antibody measurement
86706 Hepatitis b surface antibody measurement
86708 Measurement of hepatitis a antibody
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
96415 Administration of chemotherapy into vein, each additional hour
J7030 Infusion, normal saline solution , 1000 cc
90653 Influenza vaccine, inactivated
82306 Vitamin d-3 level
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
85610 Blood test, clotting time
86709 Measurement of hepatitis a antibody (igm)

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.